Form 8-K Synthetic Biologics, For: Nov 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Synthetic Biologics (SYN) Reports In-Line Q3 EPS
November 5, 2015 5:23 PM ESTSynthetic Biologics (NYSE: SYN) reported Q3 EPS of ($0.12), in-line with the analyst estimate of ($0.12).
For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.
... More